What is Annovis Bio, Inc.'s Market Cap?

Annovis Bio, Inc.'s Market Cap is $52.0M, based on as-reported figures from SEC (XBRL) filings.

What is Annovis Bio, Inc.'s Enterprise Value?

Annovis Bio, Inc.'s Enterprise Value is $33.3M, based on as-reported figures from SEC (XBRL) filings.

What is Annovis Bio, Inc.'s Revenue (TTM)?

Annovis Bio, Inc.'s Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.

What is Annovis Bio, Inc.'s Net Income (TTM)?

Annovis Bio, Inc.'s Net Income (TTM) is -$49.5M, based on as-reported figures from SEC (XBRL) filings.

What is Annovis Bio, Inc.'s Diluted EPS (TTM)?

Annovis Bio, Inc.'s Diluted EPS (TTM) is -1.16, based on as-reported figures from SEC (XBRL) filings.

What is Annovis Bio, Inc.'s Net Debt?

Annovis Bio, Inc.'s Net Debt is -$18.7M, based on as-reported figures from SEC (XBRL) filings.

Annovis Bio, Inc. (ANVS) Financial Statements

Annovis Bio, Inc.

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00PN9XDJ4

XNYS · usd

1.22▼ 0.08 (-6.15%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA—

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close1.30

Day's Range1.22 – 1.32

52-Week Range1.22 – 5.50

Volume1.7M

Avg Volume876.2K

Share Statistics

Shares Outstanding

Employees7

ExchangeXNYS

Listed2020-01-29

Share count as of August 14, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Annovis Bio, Inc. (ANVS)

What is Annovis Bio, Inc.'s Market Cap?: Annovis Bio, Inc.'s Market Cap is $52.0M, based on as-reported figures from SEC (XBRL) filings.
What is Annovis Bio, Inc.'s Enterprise Value?: Annovis Bio, Inc.'s Enterprise Value is $33.3M, based on as-reported figures from SEC (XBRL) filings.
What is Annovis Bio, Inc.'s Revenue (TTM)?: Annovis Bio, Inc.'s Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is Annovis Bio, Inc.'s Net Income (TTM)?: Annovis Bio, Inc.'s Net Income (TTM) is -$49.5M, based on as-reported figures from SEC (XBRL) filings.
What is Annovis Bio, Inc.'s Diluted EPS (TTM)?: Annovis Bio, Inc.'s Diluted EPS (TTM) is -1.16, based on as-reported figures from SEC (XBRL) filings.
What is Annovis Bio, Inc.'s Net Debt?: Annovis Bio, Inc.'s Net Debt is -$18.7M, based on as-reported figures from SEC (XBRL) filings.